Search Results - "CHITTY, DAVID W."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Kidney transplantation in patients with multiple myeloma: narrative analysis and review of the last two decades by Chitty, David W, Hartley-Brown, Monique A, Abate, Mersema, Thakur, Richa, Wanchoo, Rimda, Jhaveri, Kenar D, Nair, Vinay

    Published in Nephrology, dialysis, transplantation (22-08-2022)
    “…There have been significant advances in the treatment of multiple myeloma in the last two decades. Approximately 25% of patients with newly diagnosed myeloma…”
    Get full text
    Journal Article
  3. 3

    Less is more: An analysis of venetoclax and hypomethylating agent post-induction treatment modifications in AML by Boisclair, Stephanie, Zhou, Edward, Naing, Phyu, Thakur, Richa, Jou, Erin, Goldberg, Bradley, Gladstone, Douglas E., Allen, Steven L., Kolitz, Jonathan E., Chitty, David W.

    Published in Leukemia research (01-08-2024)
    “…Venetoclax (Ven) combined with a hypomethylating agent (HMA) enhances survival in elderly/unfit acute myeloid leukemia (AML) patients, yet often necessitates…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Assessment of Image Quality in Real Time Three-Dimensional Dobutamine Stress Echocardiography: An Integrated 2D/3D Approach by Johri, Amer M., Chitty, David W., Hua, Lanqi, Marincheva, Gergana, Picard, Michael H.

    Published in Echocardiography (Mount Kisco, N.Y.) (01-03-2015)
    “…Background Three‐dimensional (3D) stress echocardiography is a relatively new technique offering the potential to acquire images of the entire left ventricle…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Development of BMP7-producing human cells, using a third generation lentiviral gene delivery system by Chitty, David W., Tremblay, Roger G., Ribecco-Lutkiewicz, Maria, Haukenfrers, Julie, Zurakowski, Bogdan, Massie, Bernard, Sikorska, Marianna, Bani-Yaghoub, Mahmud

    Published in Journal of neuroscience methods (30-03-2012)
    “…► A third generation BMP7 lentiviral vector was developed and tested in several in vitro models. ► SMAD phosphorylation and neuronal differentiation assays…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Survival Outcomes Associated with Molecular and Cytogenetic Alterations in AML Patients Treated with Hypomethylating Agent and Venetoclax by Boisclair, Stephanie, Naing, Phyu Thin, Zhou, Edward, Thakur, Richa, Goldberg, Bradley, Jou, Erin, Chitty, David W, Kolitz, Jonathan E

    Published in Blood (02-11-2023)
    “…Molecular profiling has improved prognostication and helped identify novel therapeutic targets in AML. Nonetheless, it has also created a complex web of…”
    Get full text
    Journal Article
  10. 10

    Outcomes and Hospital Resource Utilization Associated with Decreased Ven Exposure in Acute Myeloid Leukemia Patients: A Real-World Retrospective Review by Boisclair, Stephanie, Naing, Phyu Thin, Zhou, Edward, Thakur, Richa, Jou, Erin, Goldberg, Bradley, Chitty, David W, Kolitz, Jonathan E

    Published in Blood (02-11-2023)
    “…Patients (pts) with acute myeloid leukemia who are ineligible for intensive chemotherapy are treated with hypomethylating agent (HMA) and Venetoclax (Ven). We…”
    Get full text
    Journal Article
  11. 11

    Association between Neutropenic Index for Venetoclax Exposure (NIVE) and Survival Outcomes Among AML Patients Highlighting Racial Disparities by Naing, Phyu Thin Thin, Boisclair, Stephanie, Zhou, Edward, Thakur, Richa, Jou, Erin, Goldberg, Bradley, Chitty, David W, Kolitz, Jonathan E

    Published in Blood (02-11-2023)
    “…Background Venetoclax (Ven) is a potent Bcl-2 inhibitor, approved by FDA for use in combination with hypomethylating agents (HMAs) or low dose cytarabine…”
    Get full text
    Journal Article
  12. 12

    Differences in Molecular Alterations and Clinical Outcomes By Ethnicity for Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax by Zhou, Edward, Boisclair, Stephanie, Naing, Phyu Thin, Thakur, Richa, Goldberg, Bradley, Jou, Erin, Chitty, David W, Kolitz, Jonathan E

    Published in Blood (02-11-2023)
    “…Introduction: Clinical outcomes for non-Hispanic Black and Hispanic patients with acute myeloid leukemia (AML) have been reported to be worse compared with…”
    Get full text
    Journal Article
  13. 13

    End-of-Life Outcomes in Patients with Acute Myeloid Leukemia Receiving Non-Curative Chemotherapy by Thakur, Richa, Boisclair, Stephanie, Naing, Phyu Thin, Zhou, Edward, Goldberg, Bradley, Jou, Erin, Kolitz, Jonathan E, Chitty, David W

    Published in Blood (02-11-2023)
    “…Background: Patients with acute myeloid leukemia (AML) frequently have poor-quality end of life (EOL) care including intensive care unit admissions and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The euro is born: why CPAs need to know about it by Weiner, Alan E, Chitty, David W.K

    Published in The CPA journal (1975) (01-04-1999)
    “…Born in January 1999, the euro had a gestation period of about 6 years, but the dream for a common currency as a means to unify Europe goes back to the time…”
    Get full text
    Journal Article